Prudential Financial’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,570
Closed -$251K 2306
2015
Q1
$251K Sell
2,570
-90
-3% -$8.79K ﹤0.01% 2104
2014
Q4
$247K Buy
+2,660
New +$247K ﹤0.01% 2073
2014
Q3
Sell
-5,180
Closed -$543K 2413
2014
Q2
$543K Buy
+5,180
New +$543K ﹤0.01% 1991
2013
Q3
Sell
-13,120
Closed -$551K 2347
2013
Q2
$551K Buy
+13,120
New +$551K ﹤0.01% 1914